Eko Health Launches CORE 300 AI Stethoscope
Eko Health launched its FDA cleared CORE 300 stethoscope on October 22, the company announced in a press release. The device combines traditional analog listening with digital tools in one stethoscope.
Clinicians can switch between analog and digital modes by turning the chestpiece. Digital features include amplification up to 35 times, active noise cancellation, adjustable volume and a display that shows heart rate in real time.
CORE 300 can connect to the Eko App to record, display and save heart, lung and other body sounds. The app also provides access to Eko Health's FDA cleared AI for structural murmur detection.
The device is available through Eko Health's website and is priced in line with premium traditional stethoscopes. The company plans releases in Canada, the United Kingdom and selected European markets after the US launch. Eko Health says it has delivered more than 750,000 devices.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 22 ACL Digital Launches AgentixCare for Healthcare Operations Oct 22 Epic Introduces Connectors for AI Tasks Across Health Apps Oct 22 Alethios Adds Decentralized Health Research Data Suite Oct 22 Tairex Launches Multi Agent System for Clinical Collaboration Oct 22 Genedata Adds NVIDIA RFD4-Proteina to Biologics Discovery WorkflowsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Cambridge Heartwear Wins £184 Million NHS Tender for ECG Wearable
Alethios Adds Decentralized Health Research Data Suite
ELEHEAR Launches Beyond 2 Pro AI Hearing Device
Study Tests Smartphone AI for Children's Lung Sounds
Masimo Gets FDA Clearance for AFib Detection on Radius VSM
Daily AI Brief: the AI news that matters, in your inbox.